HEC - Technological Innovation Healthy Life

HEC Trends

Share new trends in technology and health

HEC Trends

Share new trends in technology and health

2024-08

The New Electronic Material Industry Conference of HEC Group was Successfully Held in Dongguan, Guangdong

From July 31, 2024, the New Electronic Material Industry Management Conference of HEC Group was successfully held in Dongguan, Guangdong. Group chairman Zhang Yushuai, rotating chairman of the board of directors Tang Xinfa, group directors Lu Yuxin, Zhu Yingwei, Zhang Hongwei and Deng Xinhua, group supervisors Hu Zhidong, Zhou Lin and Wei Cailiang, present members of the board of directors, as well as the leaders of R&D, production, sales, functional and other departments in new electronic material industry attended this conference.

The second meeting of the ninth board of directors of HEC Group was successfully held in Yidu base, Hubei

From March 30th to 31st, 2021, the second meeting of the ninth board of directors of HEC Group was successfully held at the Yidu base in Hubei.

2021-04-02

Hengjian strategically invests in shares to help HEC take off

On February 2, 2021, Sunshine Group and Guangdong Hengjian Investment Holding Co., Ltd. (hereinafter referred to as "Guangdong Hengjian") formally reached a strategic cooperation. Guangdong Hengjian strategically invested in Guangdong Sunshine Pharmaceutical through its Guangdong Advanced Manufacturing Fund. Co., Ltd. (hereinafter referred to as "Tongyang Research"), with an investment amount of RMB 600 million and has completed the industrial and commercial change and payment procedures. This time, Guangdong Hengjian, as one of the cornerstone investors and leading investors, actively participated in this round of financing of HERO by introducing strategic investors, which shows Guangdong Hengjian's high recognition of HERO's strength, value and future development. This marks a major progress in the introduction and securitization work of TOC Research.

2021-02-04

The 2020 Expanded Meeting of the Board of Directors of HEC Group was successfully held at the Group Headquarters

From January 18th to 21st, 2021, the 2020 enlarged meeting of the board of directors of HEC Group was successfully held at the group headquarters (Changan, Dongguan).

2021-01-22

HEC Group and Dongyang Municipal Government have reached a comprehensive cooperation

On December 25, Chen Hong, Executive Deputy Mayor of Dongyang City, led the leaders of the Municipal Bureau of Commerce, Investment Promotion Center, Municipal State Investment Corporation, and Xiaoka Investment Company to visit HEC, and together with Chairman of HEC Group Zhang Yushuai, General Manager Tang Xinfa, Deputy General Manager Deng Xinhua and other staff of HEC held talks to witness the historical moment when HEC Group and Dongyang Municipal Government reached a comprehensive cooperation.

2020-12-25

After ten years of sharpening a sword, Dongweien, a class 1 anti-hepatitis C drug, was approved for marketing!

On December 22, 2020, the State Food and Drug Administration issued an announcement that through the priority review and approval process, it approved the listing of the Class 1 anti-hepatitis C innovative drug Emitasvir Phosphate Capsule (trade name: Dongweien) declared by HEC!

2020-12-22

HEC Group and Dongyang Municipal Government signed a strategic cooperation agreement

On December 18, Zhang Yushuai, chairman of the group company, led the company's directors and supervisors to return to Dongyang City for inspection, and signed a strategic cooperation agreement with the Dongyang Municipal Government.

2020-12-18

< 1 2 3 4 5 6 7 8 > proceed page

Message

Online Message

Group Email

dyg@hec.cn

Group Tel

0769-85315888

0769-88615888

WeChat public account